Managed Account Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Managed Account Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.29M	Sell	90,474 -32,434	-26%	-$549K	﹤0.01%	2009
2015 Q1	$2.13M	Sell	122,908 -42,698	-26%	-$754K	﹤0.01%	1821
2014 Q4	$2.97M	Sell	165,606 -25,999	-14%	-$419K	﹤0.01%	1644
2014 Q3	$2.52M	Buy	191,605 +739	+0.4%	+$9.95K	﹤0.01%	1719
2014 Q2	$2.74M	Buy	190,866 +33,987	+22%	+$444K	﹤0.01%	1653
2014 Q1	$2M	Buy	156,879 +14,394	+10%	+$188K	﹤0.01%	1734
2013 Q4	$1.43M	Sell	142,485 -62,105	-30%	-$705K	﹤0.01%	1819
2013 Q3	$2.69M	Sell	204,590 -30,187	-13%	-$396K	﹤0.01%	1536
2013 Q2	$3.35M	Buy	+234,777	New	+$2.95M	0.01%	1393

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Managed Account Advisors's NXTM Position: Q2 2015 in Review

Managed Account Advisors reduced its NxStage Medical Inc. (NXTM) stake by 26% in Q2 2015, selling an estimated $549K and leaving 90,474 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Managed Account Advisors first reported a position in NXTM in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.35M in Q2 2013. 139 funds tracked by Wall St. Rank hold NXTM as of Q2 2015.

Managed Account Advisors held 90,474 shares of NxStage Medical Inc. worth $1.29M as of Q2 2015.
Managed Account Advisors sold 32,434 NxStage Medical Inc. shares in Q2 2015, an estimated $549K.
NxStage Medical Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2009 holding.
Managed Account Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's NxStage Medical Inc. position peaked at $3.35M in Q2 2013.
139 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.